A shadow economy for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Experimental Drug Acquiring Traction Online
Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these profiles directly for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where groups with thousands of participants share comparison photos, administration instructions and claims of next-day British shipping. Sellers market the substance there before directing buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals injecting products of uncertain source.
Some professionals stated the demand for retatrutide could be connected to the rising cost of licensed slimming products such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.
Several content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.
Service Reaction and Content Elimination
According to TikTok, the platform has removed problematic material and prohibited related keywords and query recommendations. The company stated it was committed to maintaining the service safe and allocating resources in strengthening compliance measures.
Digital Trading Activities
Research also found communities with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of users, filled with photos of weight loss, positive reviews and step-by-step guides for mixing or administering at home.
Within minutes of entering one community, a seller shared WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about body mass, medical conditions or past usage.
Item Details and Pricing
Inside these groups, messages display dark colored packages with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how much time a injector should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Actions
A representative for Telegram stated it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has already encountered individuals harmed by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose patients to potentially serious medical dangers”.
